Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

The Plant-Based / Psychedelics Hybrid Co. “Positioned For Growth”

(Click image to play video) M eet the Company and its CEO that’s positioning itself to be the premier cannabis commercialization extractor and manufacturing partner for functional psychedelic mushroom companies. Based on extensive extractio...
Dave Jackson | November 2, 2020 |

Valeo Pharma Big Pharma Capabilities Presents Opportunity

Valeo Pharma Inc. is a Canadian specialty pharmaceutical company with big pharma capabilities while retaining small company flexibilities. Valeo is a fast-growing revenue generating company with a strong product portfolio and a robust product pipeline. Valeo Pharma In...
Fredrick William | May 15, 2020 |

PODCAST: 1933 Industries CEO and President

This podcast is part of our Cannabis Sector CEO interview series, and our mission going forward is to help listeners and investors understand more about investment opportunities in the public marketplace. Stockhouse Media's Dave Jackson was recently joined live in-studio ...
Dave Jackson | June 18, 2019 |

Arcadia Ropes in $3 Million in GoodHemp Seed Purchase Orders Within 50 Days of Product Launch

Arcadia Biosciences shares traded 25% higher after reporting that it secured $3 million in pre-season GoodHemp seed purchase commitments in just 50 days after launching the product. Arcadia Biosciences Inc. (RKDA:NASDAQ) , which employs science-based approac...
Streetwise Reports | January 31, 2020 |

Firm with Innovative HEXWAVE Product That Uses Technology Licensed from MIT and AI to Detect ...

Firm with Innovative HEXWAVE Product That Uses Technology Licensed from MIT and AI to Detect Public Shooters Begins Trading A new company with groundbreaking threat detection technology begins trading on the TSX Venture Exchange on April 9. With mass shootings oc...
Streetwise Reports | April 9, 2019 |

Siyata Mobile Accelerating Growth on Multiple Fronts

Expands its Global Footprint with Multiple New Contracts and a Key E-Commerce Distribution Agreement and Launches Innovative New Product Focusing on one specific niche market has long been a proven path to success. It’s also a potential road to failure if y...
Featured Submission | September 29, 2021 |

Led by Sales of HETLIOZ, Vanda Increases Quarterly Revenues by 25%

Shares of Vanda Pharmaceuticals traded nearly 30% higher after the company released Q2/19 earnings and positive sales trends for both HETLIOZ and Fanapt. Biopharmaceutical maker Vanda Pharmaceuticals Inc. (VNDA:NASDAQ) yesterday announced financial and ...
Streetwise Reports | August 6, 2019 |

Siyata Mobile Still Bullish After Q2 Earnings Call

Earnings reports are useful for measuring financial milestones, but they don’t tell the whole story. Siyata Mobile (NASDAQ: SYTA, SYTAW) released their Q2 earnings on an October 15th call that included CEO Marc Seelenfreund, VP of Corporate Development Daniel...
Featured Submission | October 27, 2021 |

Puma Biotech Shares Up More Than 20% on Q2 Earnings and Breast Cancer Drug Sales

Shares in Puma Biotechnology are trading 20% higher today after the company released Q2/19 earnings and reported positive NERLYNX revenue growth. Biopharmaceutical company Puma Biotechnology Inc. (PBYI:NADSAQ) shares opened more than 20% higher to...
Streetwise Reports | August 14, 2019 |

Ocular Therapeutix Shares Climb More than 25% on Q4 Revenue and Phase 1 Wet AMD Clinical Data

Ocular Therapeutix shares set a new 52-week high price after the company reported preliminary FY/19 revenue results along with positive interim data from its Phase 1 clinical study of OTX-TKI for treatment of wet age-related macular degeneration. Ocular Ther...
Streetwise Reports | March 5, 2020 |
1 2 3 4 5 6 7 8 9 10 ...